The dysregulation of RBPs, including HuR, PTB, and YTHDF1, is linked to metabolic diseases such as obesity, diabetes, and non-alcoholic fatty liver disease. This evidence concerns the gene ELAVL1 and obesity due to melanocortin 4 receptor deficiency.